Клинические рекомендации по диагностике латентной туберкулезной инфекции и химиопрофилактике заболевания в группах риска у взрослых

1. Туберкулез в Российской Федерации 2012/2013/2014 гг. Аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. – М., 2015. – 312 с.

2. Akolo C., Adetifa I., Shepperd S. et al. Treatment of latent tuberculosis infection in HIV infected persons // Cochrane Database Syst. Rev. – 2010. – 1:CD000171.

3. CattamanchiA., Smith R., SteingartK. et al. Interferon-gamma release assays for the diagnosis of tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis// J. Acquir. Immune Defic. Syndr. – 2011. – v. 56. – P. 230-238.

4. Deville W., Buntinx F., Bouter L. et al. Conducting systematic reviews of diagnostic studies: didactic guidelines// BMC Med. Res. Methodol. – 2002. – v. 2. – P. 9.

5. Diel R., Goletti D., Ferrara G. et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis // Eur. Respir. J.–2011. – v. 37 (1). – P. 88-99.

6. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active tuberculosis: a metaanalysis // Chest. – 2009. – v. 137. – P. 952-968.

7. Diel R., Loddenkemper R., Niemann S. et al. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update // Am. J. Respir. Crit. Care Med. – 2011. – v. 183. – P. 88-95.

8. Diel R., Loddenkemper R., Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis // Chest. – 2012. – v. 142. – Р. 63-75.

9. Esmail H., Barry C., Young D., Wilkinson R. The ongoing challenge of latent tuberculosis// DOI: 10.1098/rstb.2013.0437 Published 12 May 2014.

10. Ferebee S. Controlled chemoprophylaxis trials in tuberculosis: a general review // Bibl. Tuberc. – 1970. – v. 26. – P. 28-106.

11. Fox G., Barry S., Britton W., Marks G. Contact investigation for tuberculosis: a systematic review and meta-analysis // Eur. Respir. J. – 2012. – v. 41. – P. 140-156.

12. Fox W., Ellard G., Mitchison D. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications // Int. J. Tuberc. Lung Dis. – 1999. – v. 3. – S. 231-279.

13. Fox B., Kramer M., Mor Z. et al. The QuantiFERON-TB GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis // Lung. – 2009. – v. 187 (6). – P. 413-419.

14. Goletti D., Stefania C., Butera O. et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET Study // PLoSOne. – 2008. – v. 3. – e3417.

15. Jo K., Hong Y., Park J. et al. Prevalence of latent tuberculosis infection among health care workers in South Korea: A Multicenter Study // Tuberc. Respir. Dis. (Seoul). – 2013. – v. 75 (1). – P. 18-24.

16. Joshi R., Reingold A.L., Menzies D., Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review // PLoS Med. – 2006. – v. 3 (12). – e494.

17. Leeflang M., Deeks J., Gatsonis C. et al. Systematic reviews of diagnostic test accuracy // Ann. Intern. Med. – 2008. – v. 149. – P. 889-897.

18. Li J. et al. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000 // Clin. Infect. Dis. – 2005. – v. 41. – P. 83-91.

19. Lijmer J., Bossuyt P., Heisterkamp S. Exploring sources of heterogeneity in systematic reviews of diagnostic tests // Stat. Med. – 2002. – v. 21. – P. 1525-1537.

20. Ling D., Pai M., Davids V. et al. Incremental value of interferon-gamma release assays for diagnosis of active tuberculosis in smear-negative patients in a high-burden setting: a multivariable analysis // Am. J. Respir. Crit. Care Med. – 2010. – v. 181. – A2262. (American Thoracic Society International Conference; 2010; New Orleans, LA.).

21. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research // Ann. Intern. Med. – 2007. – v. 146. – P. 340-354.

22. Menzies D., Gardiner G., Farhat M. et al. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results // Int. J. Tuberc. Lung Dis. – 2008. – v. 12. – P. 498-505.

23. Metcalfe J., Everett C., Steingart K. et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis // J. Infect. Dis. – 2011. – v. 204. – S1120-S1129.

24. Pai M., Riley L., Colford J. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review // Lancet Infect. Dis. – 2004. – v. 4. – P. 761-776.

25. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update // Ann. Intern. Med. – 2008. – v. 149. – P. 177-184.

26. Rangaka M., Wilkinson K., Glynn J. et. al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis // Lancet Infect. Dis.–2011. – v. 12. – P. 45-55.

27. Rutter C., Gatsonis C. A hierarchical regression approach to meta–analysis of diagnostic test accuracy evaluations // Stat. Med. – 2001. – v. 20. – P. 2865-2884.

28. Seidler A., Nienhaus A., Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas // Respiration. – 2005. – v.72. – P. 431-446.

29. Sharma S., Sharma A., Kadhiravan T., Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB // Cochrane Database Syst. Rev. – 2013. – v. 7. – CD007545.

30. Singh J., Wells G., Christensen R. et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview // Cochrane Database Syst. Rev. – 2011. – Issue 2. – CD008794.

31. Smieja M., Marchetti C., Cook D., Smaill F. Isoniazid for preventing tuberculosis in non-HIV infected persons // Cochrane Database Syst. Rev. – 2000.– v. 2000.–CD001363.

32. Stagg H. Treatment of latent tuberculosis infection: a network meta-analysis // Ann. Intern. Med. – 2014. – v. 161. – N. 6. – P. 419-428.

33. Steele M., Burk R., DesPrez R. Toxic hepatitis with isoniazid and rifampin. A meta-analysis // Chest. – 1991. – v. 99. – P. 465-471.

34. Trajman A., Steffen R.E., Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence // Pulm. Med. – 2013. – v.2013. – P. 601-737.

35. Treglia G., Taralli S., Calcagni M.L. et al. Is there a role for fluorine-18-fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review // J. Comput. Assist. Tomogr. –

36. – v. 35. – P. 387-393.

37. Wang L., Turner M., Elwood R. et al. A meta-analysis of the effect of Bacille Calmette-Guérin vaccination on tuberculin skin test measurements // Thorax. – 2002. – v. 57. – P. 804-809.

38. WatkinsR., Brennan R., Plant A. Tuberculin reactivity and the risk of tuberculosis: a review // Int. J. Tuberc. Lung Dis. – 2000. – v. 4. – P. 895-903.

39. Wells G., Pertersen J., Welch V. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies and meta-analyses. [Электронный ресурс] URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. (Дата обращения 20.02.2010).

40. Wells G., Shea B., O’Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. [Электронный ресурс] URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. (Дата обращения 25.03.2010).

41. Whiting P., Rutjes A., Reitsma J. et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews // BMC Med. Res. Methodol. – 2003. – v. 3. – P. 25.

42. WHO. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access // Recommendations for a public health approach. – 2006 revision. [Электронный ресурс] URL: http://www.who.int/hiv/pub/guidelines/ adult/en/index.

43. html.2006. (Дата обращения 01.11.2010).

44. WHO. Antiretroviral therapy for pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access // Recommendations for a public health approach. – 2006 revision. [Электронный ресурс] URL: http://www.who.int/hiv/pub/guidelines/pmtct/en/index.html.2006.(Дата обращения 01.11.2010).

45. Global report: UNAIDS report on the global AIDS epidemic. – 2013.

46. Global tuberculosis report: WHO. – 2014.

47. WHO. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resourceconstrained settings. – Geneva, 2010.

48. [Электронный ресурс] URL:http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf. (Дата обращения 01.11.2010).

49. WHO: Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: Policy Statement. 2011.– WHO/HTM/TB/2011.18. [Электронный ресурс] URL: http://www.who.int/tb/ laboratory/policystatements/en). (Дата обращения 10.10.2012).

50. Zwerling A., van den Hof S., Scholten J. et al. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review // Thorax.– 2011. (doi: http://dx.doi.org/10.1136/thx.2010.143180 published online Jan 12).